-+ 0.00%
-+ 0.00%
-+ 0.00%

CONNECT BIOPHARMA - TO ENGAGE FDA FOR PHASE 3 PROGRAM FOR RADEMIKIBART IN COPD

Reuters·09/30/2026 11:03:26